SecProbe.io

CORRESP
1
filename1.htm

Zepp Health Corporation

Huami Global Innovation Center

Building B2, Zhong’an Chuanggu Technology
Park

No. 900 Wangjiang West Road

Hefei, 230088

People’s Republic of China

June 5, 2023

VIA EDGAR

Stephen Krikorian

Morgan Youngwood

Jimmy McNamara

Jennifer Thompson

Division of Corporation Finance

Office of Technology

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 Re: Zepp Health Corporation (the “Company”)

    Form 20-F for the Fiscal Year Ended December 31,
2022

    Filed April 24, 2023

    File No. 001-38369

Ladies and Gentlemen:

This letter sets forth the
Company’s responses to the comments contained in the letter dated May 19, 2023 from the staff (the “Staff”)
of the Securities and Exchange Commission (the “Commission”) regarding the Company’s Form 20-F for the fiscal
year ended December 31, 2022 filed with the Commission on April 24, 2023 (the “2022 Form 20-F”). The
Staff’s comments are repeated below in bold and are followed by the Company’s responses thereto. All capitalized terms used
but not defined in this letter shall have the meaning ascribed to such terms in the 2022 Form 20-F.

Form 20-F for the fiscal year ended December 31, 2022

Risks Related to Our Business, page 19

 1. Please tell us your consideration of including a risk factor to indicate that your investments may
be deemed to be investment securities within the meaning of the Investment Company Act of 1940. Also, clarify the negative impact to your
business from being deemed an investment company, including the inability to raise capital through the sale of securities or to conduct
business in the United States. Finally, advise what consideration you gave to highlighting any potential liability from being considered
an investment company under the Investment Company Act.

Zepp Health Corporation

June 5, 2023

Page 2

In response to the Staff’s comment,
the Company respectfully proposes to include the following underlined disclosure in Item 3. Key Information—D. Risk Factors in its
future Form 20-F filings, subject to update and adjustments to be made in connection with any material development of the subject
matter being disclosed:

“If we are deemed to
be an investment company under the Investment Company Act of 1940, applicable restrictions could have a material adverse effect on our
business and the price of our ADSs and Class A ordinary shares.

We are not an
 ‘investment company’ and do not intend to become registered as an ‘investment company’ under the Investment Company
Act of 1940 (the ‘Investment Company Act’), because our primary business is the development of smart wearable health and consumer
fitness devices.

Generally,
a company is an ‘investment company’ if it is or holds itself out as being engaged primarily in the business of investing,
reinvesting or trading in securities or owns or proposes to own investment securities having a value exceeding 40% of the value of its
total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis, unless an exception, exemption or safe
harbor applies. As a foreign private issuer, we would not be eligible to register under the Investment Company Act, and if a sufficient
amount of our assets are deemed to be ‘investment securities’ within the meaning of the Investment Company Act, we would either
have to obtain exemptive relief from the SEC, modify our contractual rights or dispose of investments in order to fall outside the definition
of an investment company. Additionally, we may have to forego potential future acquisitions of interests in companies that may be deemed
to be investment securities within the meaning of the Investment Company Act. Failure to avoid being deemed an investment company under
the Investment Company Act coupled with our inability as a foreign private issuer to register under the Investment Company Act could make
us unable to comply with our reporting obligations as a public company in the United States and lead to our being delisted from the NYSE,
which would have a material adverse effect on the liquidity and value of our ADSs and Class A ordinary shares. We would also be unable
to raise capital through the sale of securities in the United States or to conduct business in the United States. In addition, we may
be subject to SEC enforcement actions or civil litigation for alleged violations of U.S. securities laws. Defending ourselves against
any such enforcement action or lawsuits would require significant attention from our management and divert resources from our existing
businesses and could have a material adverse effect on our results of operations and financial condition.”

Item 16I. Disclosure Regarding Foreign Jurisdictions
that Prevent Inspections, page 141

 2. We note your statement that you reviewed public filings and the Company’s register of members
in connection with your required submission under paragraph (a). Please supplementally describe any additional materials that were reviewed
and tell us whether you relied upon any legal opinions or third party certifications such as affidavits as the basis for your submission.
In your response, please provide a similarly detailed discussion of the materials reviewed and legal opinions or third party certifications
relied upon in connection with the required disclosures under paragraphs (b)(2) and (3).

Zepp Health Corporation

June 5, 2023

Page 3

In connection with the required submission
under paragraphs (a) and (b)(3) of Item 16I, the Company respectfully submits that it relied on the Schedule 13Gs, Schedule
13Ds and the amendments thereto filed by the Company’s major shareholders. The Company believes such reliance is reasonable and
sufficient, because such major shareholders are legally obligated to file beneficial ownership schedules with the Commission. Based on
the examination of the Schedule 13Gs, Schedule 13Ds and the amendments thereto, other than HHtech Holdings Limited, People Better Limited,
Allspring entities, Shunwei High Tech Limited and FIL Limited, no shareholder beneficially owned 5% or more of the Company’s total
outstanding shares as of February 28, 2023. Additionally, none of HHtech Holdings Limited, People Better Limited, Allspring entities,
Shunwei High Tech Limited or FIL Limited was owned or controlled by a governmental entity of mainland China based on the review of the
public filings of these shareholders. Based on the foregoing, the Company believes that it is not owned or controlled by a governmental
entity of mainland China and that the governmental entities in mainland China do not have a controlling financial interest in the Company.
In addition, as disclosed in the 2022 Form 20-F, the Company is the primary beneficiary of the VIEs. It has the power to direct the
activities that most significantly affect the economic performance of the VIEs and the obligation to absorb losses or the right to receive
the economic benefits of the VIEs that could be significant to the VIEs. The shareholders of the VIEs are natural persons. Therefore,
the VIEs are not owned or controlled by a governmental entity of mainland China, and the governmental entities in mainland China do not
have a controlling financial interest in the VIEs.

In connection with the required submission
under paragraph (b)(2) of Item 16I, the Company respectfully submits that, based on its register of members as of February 28,
2023, its shareholders included: (i) Deutsche Bank Trust Company Americas; (ii) natural persons or entities wholly owned by
trusts established for the benefits of natural persons; and (iii) institutional shareholders. Deutsche Bank Trust Company Americas
is the depositary of the Company’s ADSs and acts as the attorney-in-fact for the ADS holders. It would present an undue hardship
for the Company to verify the background of each ADS holder due to the large number of such holders, and the Company could only rely on
the Schedule 13Ds, Schedule 13Gs and the amendments thereto filed by the beneficial owners of 5% or more of the Company’s shares.
Based on such public filings, none of the holders who own more than 5% of the Company’s shares is a governmental entity in the Cayman
Islands. The Company further confirms that no governmental entities in the Cayman Islands own shares of any of its shareholders which
are trusts established for the benefits of natural persons. All institutional shareholders of the Company were involved in the Company’s
pre-IPO preferred shares issuance. Based on the examination of publicly available information, such as the institutional shareholders’
websites and the Schedule 13Gs, Schedule 13Ds and the amendments thereto filed by them, to the best of our knowledge, no governmental
entities in the Cayman Islands own shares of any of the institutional shareholders. Therefore, to the best of our knowledge, no governmental
entities in the Cayman Islands own shares of the Company. In addition, as disclosed in the 2022 Form 20-F, the shareholders of the
Company’s VIEs (i.e. Anhui Huami and Beijing Huami) are all natural persons.

Zepp Health Corporation

June 5, 2023

Page 4

The Company respectfully submits that
it did not rely upon any legal opinions or third party certifications such as affidavits as the basis of its submission.

 3. In order to clarify the scope of your review, please supplementally describe the steps you have taken
to confirm that none of the members of your board or the boards of your consolidated foreign operating entities are officials of the Chinese
Communist Party. For instance, please tell us how the board members’ current or prior memberships on, or affiliations with, committees
of the Chinese Communist Party factored into your determination. In addition, please tell us whether you have relied upon third party
certifications such as affidavits as the basis for your disclosure.

The Company respectfully submits that
it has asked all of its directors to complete a questionnaire as part of its annual compliance procedures. Each director confirmed in
such questionnaire that such director is not an official of the Chinese Communist Party. In addition, the Company respectfully submits
that, except for Mr. Bin Fan and Mr. Yajun Zhao, none of its consolidated foreign operating entities has a director who is not
a director of the Company. Mr. Bin Fan and Mr. Yajun Zhao are employees of the Company and are directors of several of the Company’s
consolidated foreign operating entities. Based on the employment profiles of the two employees retained by the Company, the Company confirms
that Mr. Bin Fan and Mr. Yajun Zhao are not officials of the Chinese Communist Party.

 4. We note that your disclosures pursuant to Items 16I(b)(2), (b)(3) and (b)(5) are provided
for “Zepp Health Corporation or the VIEs.” We also note that your disclosures on pages 5 and 89 and the list of principal
subsidiaries in Exhibit 8.1 indicate that you have consolidated foreign operating entities in Hong Kong and countries outside China
that are not included in your VIEs. Please note that Item 16I(b) requires that you provide disclosures for yourself and your consolidated
foreign operating entities, including variable interest entities or similar structures.

 ● With respect to (b)(2), please supplementally clarify the jurisdictions in which your material consolidated
foreign operating entities are organized or incorporated and confirm, if true, that you have disclosed the percentage of your shares or
the shares of your consolidated operating entities owned by governmental entities in each foreign jurisdiction in which you have consolidated
operating entities. Alternatively, provide this information in your supplemental response.

Zepp Health Corporation

June 5, 2023

Page 5

With respect to the required submission
under paragraph (b)(2) of Item 16I, the Company respectfully submits that the jurisdictions in which the Company’s material
consolidated foreign operating entities are incorporated include the United States, Hong Kong, the Netherlands and mainland China. Except
for the VIEs, Huzhou Huayuan Chuangxu Management Consulting Partnership (Limited Partnership) and Anhui Shunyuan Xinke Management Consulting
Partnership (Limited Partnership), the Company holds 100% equity interests in such material consolidated operating entities. In terms
of Huzhou Huayuan Chuangxu Management Consulting Partnership (Limited Partnership), the Company holds 86.58% equity interest. The rest
of the equity interest of Huzhou Huayuan Chuangxu Management Consulting Partnership (Limited Partnership) is held by a natural person.
In terms of Anhui Shunyuan Xinke Management Consulting Partnership (Limited Partnership), the Company holds 96.67% equity interest. The
rest of the equity interest of Anhui Shunyuan Xinke Management Consulting Partnership (Limited Partnership) is held by a natural person.
Therefore, to the best of our knowledge, no governmental entities in the United States, Hong Kong, the Netherlands, or mainland China
own shares of the Company’s material consolidated foreign operating entities.

 ● With respect to (b)(3) and (b)(5), please provide the information required by (b)(3) and
(b)(5) for you and all of your consolidated foreign operating entities in your supplemental response.

With respect to the required submission
under paragraphs (b)(3) of Item 16I, the Company respectfully submits that, based on the analysis in the previous paragraph, the
governmental entities in mainland China do not have a controlling financial interest in the Company’s material consolidated foreign
operating entities. With respect to the required submission under paragraphs (b)(5) of Item 16I, the Company confirms that the articles
of its material consolidated foreign operating entities do not contain any charter of the Chinese Communist Party.

 5. With respect to your disclosure pursuant to Item 16I(b)(5), we note that you have included language
that such disclosure is “to our knowledge”. Please supplementally confirm without qualification, if true, that your articles
and the articles of your consolidated foreign operating entities do not contain wording from any charter of the Chinese Communist Party.

The Company confirms without qualification
that its articles and the articles of its consolidated foreign operating entities do not contain wording from any charter of the Chinese
Communist Party.

*          *          *

 Very truly yours,

  /s/
Leon Cheng Deng

  Leon
Cheng Deng

  Chief Financial Officer

 cc: Wang Huang, Chairman of the Board of Directors and Chief Executive Officer, Zepp Health Corporation

Haiping Li, Partner, Skadden, Arps, Slate, Meagher &
Flom LLP

Yilin Xu, Partner, Skadden, Arps, Slate, Meagher &
Flom LLP

Jason Zhang, Partner, Deloitte Touche Tohmatsu
Certified Public Accountants LLP